Please wait
MAYBAKER (MAYBAKER) is listed on the Nigerian Exchange in the HEALTHCARE sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
HEALTHCARE
₦69B
1.0%
15.11
Current price
₦40.00
Updated Updated 1d ago
Conviction
79/100
Confidence
Low
Market tone
neutral · 50/100
Entry
Medium · 79/100
Recent price action for MAYBAKER, so the page starts with the stock itself before the deeper analysis.
Liquidity looks fair, but slippage can still happen if order size is too big.
Valuation view
Looks relatively cheap vs peers
Income view
Low income profile
Market tone
neutral (50/100) — price action, attention, and recent context all lean here.
Entry view
Medium (79/100) — The company is profitable on the latest reported numbers.
Maybaker is a company in the pharmaceutical preparations industry that develops, manufactures, or distributes medicines and related health products. It makes money by selling those pharmaceutical products to hospitals, pharmacies, and other customers, earning revenue from product sales and distribution.
Investors usually follow MAYBAKER for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Director dealings
0
Reported buys, sells, and mixed dealings.
Corporate actions
6
Dividend and company notices.
Market events
0
Insider, filing, dividend, and price events.
Source records
13
Captured updates we can trace.
Whisone is bullish because fundamentals are solid at 79/100 while today's volume is only 28% of average. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
35.2%
Return on equity
ROA
14.9%
Return on assets
Debt / equity
0.28
Lower is usually safer.
P/B ratio
8.65
Useful for book value support.
Dividend yield
1.0%
Current income signal.
77/100
Direction
Cautious
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Valuation still leaves room versus fair value and analyst anchors.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Liquidity looks thin, so even a good thesis may take longer to show up in price.
Fair value
₦57.43
Analyst view
n/a
Forecast refresh
Updated 22h ago
Quality score
78
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
Updated 1d ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 2d ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 3d ago
Bulk intraday company price snapshot from NGXPulse.
NGX Pulse bulk price snapshot
Updated 4d ago
Bulk intraday company price snapshot from NGXPulse.
Price points saved
50
Latest market date
2026-06-24
Dividend yield
1.0%
Ex-dividend date
May 20, 2026
Price: ₦101.20
P/E: 21.95
Yield: 1.5%
MECURE
MECURE
Price: ₦94.90
P/E: N/A
Yield: N/A
Industry
Pharmaceutical Preparations
Founded
1944
Employees
414
Ticker
MAYBAKER
Estimated earnings date
2026-04-28
